Adolescent outpatient treatment and continuing care: main findings from a randomized clinical trial.
This study evaluated the effectiveness and cost-effectiveness of two types of outpatient treatment with and without Assertive Continuing Care (ACC) for 320 adolescents with substance use disorders. Study participants were randomly assigned to one of four conditions: (a) Chestnut's Bloomington Outpatient Treatment (CBOP) without ACC; (b) CBOP with ACC; (c) Motivational Enhancement Therapy/Cognitive Behavior Therapy-7 session model (MET/CBT7) without ACC; and (d) MET/CBT7 with ACC. All study conditions attained high rates of participant engagement and retention. Follow-up interviews were completed with over 90% of the adolescents at three, six, nine, and 12 months after treatment admission. There was a significant time by condition effect over 12 months, with CBOP having a slight advantage for average percentage of days abstinent. Unlike previous findings that ACC provided incremental effectiveness following residential treatment, there were no statistically significant findings with regard to the incremental effectiveness of ACC following outpatient treatment. Analysis of the costs of each intervention combined with its outcomes revealed that the most cost-effective condition was MET/CBT7 without ACC.
Godley
Susan H
SH
Chestnut Health Systems, Lighthouse Institute, 448 Wylie Drive, Normal, IL 61761, USA. sgodley@chestnut.org
Garner
Bryan R
BR
Passetti
Lora L
LL
Funk
Rodney R
RR
Dennis
Michael L
ML
Godley
Mark D
MD
D000293:Adolescent; D000553:Ambulatory Care / Q000191:economics / Q000706:statistics & numerical data*; D001521:Behavior Therapy; D015928:Cognitive Behavioral Therapy; D003362:Cost-Benefit Analysis; D003416:Criminal Law; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007087:Illinois / Q000453:epidemiology; D016014:Linear Models; D008297:Male; D009042:Motivation; D012424:Rural Population; D019966:Substance-Related Disorders / Q000191:economics / Q000523:psychology / Q000534:rehabilitation*; D016896:Treatment Outcome; D014505:Urban Population